These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1668120)

  • 1. IgA immune aggregates stimulate platelet-activating factor and superoxide anion production by human neutrophils. A comparison with IgG aggregates.
    Hernando P; Egido J; de Nicolas R; Gonzalez E
    Lipids; 1991 Dec; 26(12):1231-5. PubMed ID: 1668120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of platelet-activating factor (PAF) in superoxide production by human polymorphonuclear leukocytes.
    Takahashi S; Yoshikawa T; Naito Y; Tanigawa T; Yoshida N; Kondo M
    Lipids; 1991 Dec; 26(12):1227-30. PubMed ID: 1668119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.
    Sisson JH; Prescott SM; McIntyre TM; Zimmerman GA
    J Immunol; 1987 Jun; 138(11):3918-26. PubMed ID: 3035016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes.
    Bussolati B; Mariano F; Montrucchio G; Piccoli G; Camussi G
    Immunology; 1997 Mar; 90(3):440-7. PubMed ID: 9155653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis.
    Laffi G; Carloni V; Baldi E; Rossi ME; Azzari C; Gresele P; Marra F; Gentilini P
    Gastroenterology; 1993 Jul; 105(1):170-7. PubMed ID: 8390378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionyl-leucyl-phenylalanine.
    Wirthmueller U; De Weck AL; Dahinden CA
    J Immunol; 1989 May; 142(9):3213-8. PubMed ID: 2540238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor.
    Ingraham LM; Coates TD; Allen JM; Higgins CP; Baehner RL; Boxer LA
    Blood; 1982 Jun; 59(6):1259-66. PubMed ID: 6282362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of ionized cytoplasmic calcium mobilization with the photoprotein aequorin in human polymorphonuclear leukocytes activated by platelet activating factor (PAF).
    Del Maschio A; Albors M; Evangelista V; Bucchi F; Bertelé V; Cerletti C; de Gaetano G
    J Lipid Mediat; 1989; 1(1):25-36. PubMed ID: 2562430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.
    Stewart AG; Harris T; De Nichilo M; Lopez AF
    Immunology; 1991 Feb; 72(2):206-12. PubMed ID: 1849872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.
    Camussi G; Bussolino F; Salvidio G; Baglioni C
    J Exp Med; 1987 Nov; 166(5):1390-404. PubMed ID: 3119758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis.
    Bussolati B; Mariano F; Cignetti A; Guarini A; Cambi V; Foà R; Piccoli G; Camussi G
    J Immunol; 1998 Aug; 161(3):1493-500. PubMed ID: 9686616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming.
    Bauldry SA; McCall CE; Cousart SL; Bass DA
    J Immunol; 1991 Feb; 146(4):1277-85. PubMed ID: 1846897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapulmonary tumor necrosis factor triggers local platelet-activating factor production in rat immune complex alveolitis.
    Warren JS; Barton PA; Mandel DM; Matrosic K
    Lab Invest; 1990 Dec; 63(6):746-54. PubMed ID: 2255183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor.
    Breviario F; Bertocchi F; Dejana E; Bussolino F
    J Immunol; 1988 Nov; 141(10):3391-7. PubMed ID: 3263425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAF-acether, superoxide anion and beta-glucuronidase as parameters of polymorphonuclear cell activation associated with cardiac surgery and cardiopulmonary bypass.
    Hoshikawa-Fujimura AY; Auler Júnior JO; Da Rocha TR; Brandizzi LI; Pascual JM; Chamone DA; Jatene AD
    Braz J Med Biol Res; 1989; 22(9):1077-82. PubMed ID: 2561459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular Ca2+.
    Ludwig JC; McManus LM; Clark PO; Hanahan DJ; Pinckard RN
    Arch Biochem Biophys; 1984 Jul; 232(1):102-10. PubMed ID: 6430234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation.
    Camussi G; Tetta C; Bussolino F; Caligaris Cappio F; Coda R; Masera C; Segoloni G
    Int Arch Allergy Appl Immunol; 1981; 64(1):25-41. PubMed ID: 7450901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet modulation of neutrophil superoxide anion production.
    Moon DG; van der Zee H; Weston LK; Gudewicz PW; Fenton JW; Kaplan JE
    Thromb Haemost; 1990 Feb; 63(1):91-6. PubMed ID: 2160133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteins.
    Braquet P; Hosford D; Koltz P; Guilbaud J; Paubert-Braquet M
    Lipids; 1991 Dec; 26(12):1071-5. PubMed ID: 1668107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lexipafant inhibits platelet activating factor enhanced neutrophil functions.
    Schwartz JD; Shamamian P; Grossi EA; Schwartz DS; Marcus SG; Steiner F; Jacobs CE; Tayyarah M; Eng K; Colvin SB; Galloway AC
    J Surg Res; 1997 May; 69(2):240-8. PubMed ID: 9224389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.